about
RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory elementAkt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα).Human leukocyte formin: a novel protein expressed in lymphoid malignancies and associated with Akt.Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in mice.Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer.Using RNA interference in lung cancer cells to target the IKK-NF-κB pathway.Expression of spectrin alphaI/50 hereditary elliptocytosis and its association with the alphaLELY allele.Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy.Presence of allele alphaLELY in an Amazonian Indian population.Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment.Erythrocyte Ankyrin Promoter Mutations Associated with Recessive Hereditary Spherocytosis Cause Significant Abnormalities in Ankyrin ExpressionAssociation of the alpha-spectrin R28H mutation with allele alphaLELY and with alphaI/alphaII domain haplotypes in three Brazilian familiesMutation Analysis of the HFE Gene in Brazilian Populationsbeta-Spectrin Campinas: a novel shortened beta-chain variant associated with skipping of exon 30 and hereditary elliptocytosisCa2+-dependent permeabilization of the inner mitochondrial membrane by 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS)Low frequency of ankyrin mutations in hereditary spherocytosis: identification of three novel mutationsAurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancerWhere do we aspire to publish? A position paper on scientific communication in biochemistry and molecular biology
P50
Q24336420-D4D84FFF-BCC7-4168-9839-2D20A99DCEEEQ34139142-301AB848-E6DA-4C80-8001-C7FB615544B7Q34273594-DC9AE2D9-1462-4B4F-B554-1DD670469A79Q34302408-EB2436B0-86CA-4F9D-80A3-54102AA3D8A7Q36228256-6C7C2C6F-25EC-4FD7-8D96-B99094DA264FQ38339951-7E80743B-236E-47C4-8553-29DA95FC0A56Q38903961-646A080C-BD86-4A40-A348-959C97D71000Q44693920-C14DEF84-B823-43D7-9216-E3DB44CCECB7Q47720751-ADE495C1-B420-47DC-AA1E-5A127C2445D4Q47768550-296E1450-F705-455A-996C-8B3D02D9C20CQ50191139-1A29FBFC-134F-4640-BEC4-A132D3C74DE4Q57580018-DB93F4AE-FBF7-4F2A-B8F6-9FB4C2F1374FQ57580022-CD994A4D-6404-4EFA-90C8-BFEA19329972Q57580030-E0EE30FA-0426-460A-A56E-F4FB8564E155Q57580035-0DDD65EC-8113-4808-9ED6-CF6C20DB7C8BQ57580039-6699D614-7795-47D1-8A24-907B9F550EB0Q73260163-64946C5A-1D1E-4276-9D66-8B15D23B5980Q90473926-9FCA3E38-4DBB-45D2-9F3C-0119F59B9A23Q93094005-24E847B0-7DB3-48AE-8774-9F0112A8567A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniela Bassères
@ast
Daniela Bassères
@en
Daniela Bassères
@es
Daniela Bassères
@fr
Daniela Bassères
@nl
Daniela Bassères
@sl
type
label
Daniela Bassères
@ast
Daniela Bassères
@en
Daniela Bassères
@es
Daniela Bassères
@fr
Daniela Bassères
@nl
Daniela Bassères
@sl
prefLabel
Daniela Bassères
@ast
Daniela Bassères
@en
Daniela Bassères
@es
Daniela Bassères
@fr
Daniela Bassères
@nl
Daniela Bassères
@sl
P1053
C-6623-2013
P106
P21
P31
P3829
P496
0000-0001-7745-3567